Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ROMOSOZUMAB
- A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.
- The Optimised Use of Romozosumab Study
- Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
- A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
- Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
- A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
- Romosozumab Use to Build Skeletal Integrity
- Anabolic Therapy in Postmenopausal Osteoporosis
- Romosozumab/Denosumab Study for Premenopausal IOP
- Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa
- Romosozumab in Women With Chronic SCI
- Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
- Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta
- Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
- Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users
- A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
- A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis
- A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis
- A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis
- Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
- Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)
- An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
- Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
- Transition From Alendronate to Romosozumab (AMG 785)
- Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
- A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women
- Study To Assess FRacTure Healing With SclerosTin Antibody - Hip
- A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women
- A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass
- Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing
- Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
Clinical trials list
click for details